These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8644624)

  • 21. Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs.
    Sen L; Cui G; Sakaguchi Y; Singh BN
    J Pharmacol Exp Ther; 1998 May; 285(2):687-94. PubMed ID: 9580614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sotalol exhibits reverse use-dependent action on monophasic action potentials in normal but not in infarcted canine ventricular myocardium.
    Schmitt C; Beyer T; Karch M; Montero M; Hilbel T; Brachmann J; Kübler W
    J Cardiovasc Pharmacol; 1992 Apr; 19(4):487-92. PubMed ID: 1380589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of dofetilide on cardiac repolarization in patients with ventricular tachycardia. A study using simultaneous monophasic action potential recordings from two sites in the right ventricle.
    Yuan S; Wohlfart B; Rasmussen HS; Olsson S; Blomström-Lundqvist C
    Eur Heart J; 1994 Apr; 15(4):514-22. PubMed ID: 8070479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of sotalol and d-sotalol on ventricular tachycardia and fibrillation induced by programmed electrical stimulation.
    Aliot E; Sadoul N; De Chillou C
    Eur Heart J; 1993 Nov; 14 Suppl H():74-7. PubMed ID: 7904940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolongation of monophasic action potential duration and the refractory period in the human heart by tedisamil, a new potassium-blocking agent.
    Bargheer K; Bode F; Klein HU; Trappe HJ; Franz MR; Lichtlen PR
    Eur Heart J; 1994 Oct; 15(10):1409-14. PubMed ID: 7821321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiologic basis for the antiarrhythmic actions of sotalol and comparison with other agents.
    Singh BN
    Am J Cardiol; 1993 Aug; 72(4):8A-18A. PubMed ID: 8346731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between the effective refractory period and activation-recovery interval calculated from the intracardiac unipolar electrogram of humans with and without dl-sotalol treatment.
    Chinushi M; Tagawa M; Kasai H; Washizuka T; Abe A; Furushima H; Aizawa Y
    Jpn Circ J; 2001 Aug; 65(8):702-6. PubMed ID: 11502045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of ranolazine on ventricular repolarization in class III antiarrhythmic drug-treated rabbits.
    Frommeyer G; Kaiser D; Uphaus T; Kaese S; Osada N; Rajamani S; Belardinelli L; Breithardt G; Eckardt L; Milberg P
    Heart Rhythm; 2012 Dec; 9(12):2051-8. PubMed ID: 23044390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beat-to-beat variability of ventricular late potentials in the unaveraged high resolution electrocardiogram--effects of antiarrhythmic drugs.
    Höher M; Axmann J; Eggeling T; Kochs M; Weismüller P; Hombach V
    Eur Heart J; 1993 Sep; 14 Suppl E():33-9. PubMed ID: 8223753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of electrophysiologic properties between responders and non-responders to DL-sotalol among patients with ventricular tachyarrhythmia. Importance of the lack of a reverse use-dependent effect on ventricular refractoriness to responders.
    Naitoh N; Yamaura M; Tagawa M; Aizawa Y
    Jpn Heart J; 1998 Sep; 39(5):619-30. PubMed ID: 9925993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between the U wave on electrocardiogram and the midmyocardium of the left ventricular wall.
    Zhang C; Li Y; Lu Z; Wu J; Wang C
    Chin Med J (Engl); 2002 Apr; 115(4):509-12. PubMed ID: 12133285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dauricine-induced changes in monophasic action potentials and effective refractory period of rabbit left ventricle in situ.
    Xia JS; Li Z; Dong JW; Tu H; Zeng FD
    Acta Pharmacol Sin; 2002 Apr; 23(4):371-5. PubMed ID: 11931697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reverse use-dependent effects of sotalol demonstrated by recording monophasic action potentials of the right ventricle.
    Schmitt C; Brachmann J; Karch M; Waldecker B; Navarrete L; Montero M; Beyer T; Kübler W
    Am J Cardiol; 1991 Nov; 68(11):1183-7. PubMed ID: 1951078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiologic actions of d,l-sotalol and GLG-V-13 in ischemically injured canine epicardium.
    Patterson E; Scherlag BJ; Lazzara R; Garrison GL; Berlin KD
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):304-13. PubMed ID: 17878760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency-dependent electrophysiologic effects of amiodarone in humans.
    Sager PT; Uppal P; Follmer C; Antimisiaris M; Pruitt C; Singh BN
    Circulation; 1993 Sep; 88(3):1063-71. PubMed ID: 8353868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Block of IKs by the diuretic agent indapamide modulates cardiac electrophysiological effects of the class III antiarrhythmic drug dl-sotalol.
    Fiset C; Drolet B; Hamelin BA; Turgeon J
    J Pharmacol Exp Ther; 1997 Oct; 283(1):148-56. PubMed ID: 9336319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is cyclic AMP involved in the defibrillating effect of sotalol?
    Miyachi E; Manoach M; Uchiyama H; Watanabe Y
    Life Sci; 1995 Nov; 57(26):PL393-9. PubMed ID: 8847956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of sotalol and acute ventricular dilatation on action potential duration and dispersion of repolarization after defibrillation shocks.
    Kirchhof P; Milberg P; Eckardt L; Breithardt G; Haverkamp W
    J Cardiovasc Pharmacol; 2003 Apr; 41(4):640-8. PubMed ID: 12658067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of sotalol on RR interval variability during induced ventricular tachycardia.
    Yli-Mäyry S; García-Alberola A; Haverkamp W; Hindricks G; Martínez-Rubio A; Borggrefe M; Breithardt G
    Am J Cardiol; 1996 Aug; 78(3):372-6. PubMed ID: 8759826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute inhibition of the Na(+)/Ca(2+) exchanger reduces proarrhythmia in an experimental model of chronic heart failure.
    Milberg P; Pott C; Frommeyer G; Fink M; Ruhe M; Matsuda T; Baba A; Klocke R; Quang TH; Nikol S; Stypmann J; Osada N; Müller FU; Breithardt G; Noble D; Eckardt L
    Heart Rhythm; 2012 Apr; 9(4):570-8. PubMed ID: 22075452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.